Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

KL Woods, S Fletcher, CH Roffe, Y Haider - The Lancet, 1992 - Elsevier
The cardiovascular actions of the magnesium ion at pharmacological concentrations
include coronary and systemic vasodilatation, platelet inhibition, and antiarrhythmic effects. …

A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction

…, JR Thompson, L O'Toole, K Channer, KL Woods - Circulation, 1996 - Am Heart Assoc
Background The ACE gene is characterized by a polymorphism based on the presence (insertion
[I]) or absence (deletion [D]) within intron 16 of a 287-basepair alu repeat sequence, …

Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial …

KL Woods, S Fletcher - The Lancet, 1994 - Elsevier
The second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) examined the effect
of an intravenous regimen of magnesium sulphate in 2316 patients with suspected acute …

Arterial versus capillary sampling for analysing blood gas pressures

K Dar, T Williams, R Aitken, KL Woods, S Fletcher - Bmj, 1995 - bmj.com
Methods and results We recruited 55 patients requiring measurement of blood gas pressures
from patients admitted urgently to Kettering General Hospital. The study's protocol was …

Possible pharmacological actions of magnesium in acute myocardial infarction.

KL Woods - British journal of clinical pharmacology, 1991 - ncbi.nlm.nih.gov
Seven randomised clinical trials in a total of over 1,300 patients have examined the effects
of intravenous magnesium salts (chloride or sulphate) given early after acute myocardial …

[HTML][HTML] Regulation of medicines and medical devices: contrasts and similarities

N Parvizi, K Woods - Clinical medicine, 2014 - ncbi.nlm.nih.gov
In recent times, there has been an unprecedented level of public interest and active debate
regarding the regulation of medical devices. This is in light of the topical, rather dissimilar, …

Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction

KL Woods… - The Lancet, 1996 - Elsevier
Background There is conclusive evidence from clinical trials that thrombolytic therapy reduces
mortality in acute myocardial infarction (AMI). But still only a minority of patients admitted …

Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction: Towards an understanding of factors influencing clinical …

KL Woods, D Ketley, A Lowy, A Agusti… - European heart …, 1998 - academic.oup.com
Aims Long-term beta-blockade reduced mortality after acute myocardial infarction by about
a quarter in a series of published trials. Representative data on beta-blocker use for …

32P-Postlabelled DNA adducts in liver obtained from women treated with tamoxifen

EA Martin, KJ Rich, INH White, KL Woods… - …, 1995 - academic.oup.com
32 P-Postlabelling of DNA extracted from the livers obtained from seven women receiving
tamoxifen (20 mg either once or twice daily) was compared with liver DNA from seven …

Three‐lead measurement of QTc dispersion

JM Glancy, CJ Garratt, KL Woods… - Journal of …, 1995 - Wiley Online Library
QTc Dispersion. Introduction: QTc dispersion has traditionally been calculated from all 12
leads of a standard electrocardiogram (ECG). It is possible that alternative, quicker methods …